Skip to main content
. 2024 Jul 29;19(7):e0300947. doi: 10.1371/journal.pone.0300947

Fig 3. Prevalence of individual symptoms at 3-months post-SARS-CoV-2 infection by missed workdays and return to work status.

Fig 3